Sophocarpine Inhibits Proliferation and Triggers Apoptosis in Breast Cancer Cells by Modulating the miR-21/PTEN/AKT and ERK1/2 Signaling Networks.
- 1Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.
- 2Department of Physiology, Medical Research Institute, Alexandria University, Alexandria 21511, Egypt.
Abstract
Background: Sophocarpine (SC), a tetracyclic quinolizidine alkaloid, has shown antitumor potential, yet its activity and underlying mechanisms in breast cancer remain unexplored. This study aimed to investigate the anticancer effects of SC and the molecular mechanism, focusing on the involvement of microRNA-21 (miR-21) and AKT/mTOR and ERK1/2 signaling networks. Methods: In MDA-MB-231 and T-47D breast cancer cells, SC cytotoxicity and growth-inhibitory effects were evaluated using MTT viability, colony formation, migration assays, and flow cytometry for cell cycle and apoptosis analysis. RT-qPCR analysis, Western blotting, and immunofluorescence staining were performed to measure RNA and protein expression, respectively. Molecular docking analysis was performed to explore SC's interaction with the miR-21 precursor. Results: SC treatment effectively inhibited the proliferation, survival, and migration of breast cancer cells. It also induced cell cycle arrest and triggered apoptosis in both cell lines. Mechanistically, SC downregulated oncogenic miR-21 transcription, thereby enhancing tumor suppressors PTEN and PDCD4 and suppressing AKT/mTOR and ERK1/2 signaling. Interestingly, restoration of miR-21 reversed SC's effects on PTEN and PDCD4, confirming SC's miR-21 dependency. Docking analysis suggested that SC may bind the miR-21 precursor and interfere with its maturation. SC also increased long noncoding RNA GAS5 while reducing miR-196a-5p and HIF-1α transcripts. It shifted the Bcl2/Bax/Bad/caspases balance toward apoptosis. Conclusions: These findings identify SC as a potential structural scaffold exhibiting preliminary anti-tumor activity against breast cancer cells, at least in part, through modulating miR-21 and inhibition of the AKT/mTOR/ERK1/2 survival network.
Related
- Targeting P2Y₁₄R inhibits proliferation of cervical cancer cells and organoids and activates cAMP/PKA/CREB signaling pathway.
- Miltirone suppresses proliferation and induces apoptosis in ovarian cancer cells in association with modulation of the RBM15/E2F2/PI3K/Akt signaling axis
- Honokiol induces an autophagy and apoptosis imbalance by modulating the p62 and Nrf2 signaling loop in canine osteosarcoma
- Perioperative sophocarpine protects against testicular ischemia/reperfusion injury by blocking JNK/p38 signaling
- Fisetin Induces Apoptosis and Inhibits Migration of Melanoma Cells by Suppressing Glycolytic Metabolism via PKM2 Inhibition.
BibTeX
@article{shahin2026sophocarpine,
title = {{Sophocarpine Inhibits Proliferation and Triggers Apoptosis in Breast Cancer Cells by Modulating the miR-21/PTEN/AKT and ERK1/2 Signaling Networks.}},
author = {Yasmin R Shahin and Nihal M Elguindy and Doaa A Ghareeb and Seham Elabd and Mahmoud Balbaa},
journal = {Pharmaceuticals (Basel, Switzerland)},
year = {2026},
month = sep,
doi = {10.3390/ph19101513},
url = {https://europepmc.org/article/MED/42943210},
note = {CC BY},
}
RIS
TY - JOUR
TI - Sophocarpine Inhibits Proliferation and Triggers Apoptosis in Breast Cancer Cells by Modulating the miR-21/PTEN/AKT and ERK1/2 Signaling Networks.
AU - Yasmin R Shahin
AU - Nihal M Elguindy
AU - Doaa A Ghareeb
AU - Seham Elabd
AU - Mahmoud Balbaa
PY - 2026
DA - 2026/09/23
JO - Pharmaceuticals (Basel, Switzerland)
DO - 10.3390/ph19101513
UR - https://europepmc.org/article/MED/42943210
AB - Background: Sophocarpine (SC), a tetracyclic quinolizidine alkaloid, has shown antitumor potential, yet its activity and underlying mechanisms in breast cancer remain unexplored. This study aimed to investigate the anticancer effects of SC and the molecular mechanism, focusing on the involvement of microRNA-21 (miR-21) and AKT/mTOR and ERK1/2 signaling networks. Methods: In MDA-MB-231 and T-47D breast cancer cells, SC cytotoxicity and growth-inhibitory effects were evaluated using MTT viability, colony formation, migration assays, and flow cytometry for cell cycle and apoptosis analysis. RT-qPCR analysis, Western blotting, and immunofluorescence staining were performed to measure RNA and protein expression, respectively. Molecular docking analysis was performed to explore SC's interaction with the miR-21 precursor. Results: SC treatment effectively inhibited the proliferation, survival, and migration of breast cancer cells. It also induced cell cycle arrest and triggered apoptosis in both cell lines. Mechanistically, SC downregulated oncogenic miR-21 transcription, thereby enhancing tumor suppressors PTEN and PDCD4 and suppressing AKT/mTOR and ERK1/2 signaling. Interestingly, restoration of miR-21 reversed SC's effects on PTEN and PDCD4, confirming SC's miR-21 dependency. Docking analysis suggested that SC may bind the miR-21 precursor and interfere with its maturation. SC also increased long noncoding RNA GAS5 while reducing miR-196a-5p and HIF-1α transcripts. It shifted the Bcl2/Bax/Bad/caspases balance toward apoptosis. Conclusions: These findings identify SC as a potential structural scaffold exhibiting preliminary anti-tumor activity against breast cancer cells, at least in part, through modulating miR-21 and inhibition of the AKT/mTOR/ERK1/2 survival network.
SN - 1424-8247
ER -